Home Top Movers Why is Aptose Biosciences Inc. (APTO) stock gaining today?

Why is Aptose Biosciences Inc. (APTO) stock gaining today?

Shares of the Aptose Biosciences Inc. (APTO) stock were gaining in the pre-market session today on June 14, 2021, despite no recent activity by APTO stock today. The APTO stock price saw a push of 4.26% to reach $3.92 a share at the time of this writing. APTO stock went down at the previous closing by 32.01% after the release of highlights of Luxeptinib at the EHA2021 virtual congress. Let’s check out more about APTO stock.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What’s Happening?

After experiencing a huge fall at previous trading, the Aptose stock has again found momentum though its rising per-share price has nothing to do with any recent news related to it or any recent analyst upgrade. However, on June 11, 2021, Aptose stock presented the highlights of the clinical status of luxeptinib at the EHA2021 Virtual Congress (EHA).

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Read More

Management View on Luxeptinib

The CEO of the Aptose stock said that the luxeptinib proved to be an active drug for several indications across both lymphoid and myeloid malignancies according to the clinical experience of the Aptose staff which shows the consistency with the hypothesis from the Aptose portfolio of pre-clinical work. The CEO further said that they are encouraged to get more exposure to this antitumor activity in the patients who were previously treated with heavy doses of other drugs and were clinically challenged by continuing the trials with heavy doses of luxeptinib in order to evaluate the potential of the drug for a longer-term.

Brief Highlights of Luxeptinib clinical program

In the phase 1a/b study of luxeptinib in patients with relapsed or refractory AML, Aptose moved to the third cohort in which patients are treated with 750mg dose of the drug and management is planning to increase the dose further and aiming to inspect the genotypes of the disease under monotherapy and combination therapy programs in future.

In the Phase 1a/b study of luxeptinib in B-cell malignancies, all the leading indicators of clinical activity had been delivered by treating participant patients with intermediate dose levels. Currently, the Aptose team is treating patients with B-cell malignancies by 750mg dose and looking forward to further increase the dose level as well as the extension of treatment duration.


Aptose stock is hot among the investors so far despite the absence of any particular reason related to APTO stock. The clinical trials of luxeptinib are expected to continue with high doses in the future. The future of the stock greatly depends on the further results of Luxeptinib.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Energous Corporation Inc. (WATT) stock declines during after-market. Here’s to know why?

Energous Corporation Inc. (WATT) stock gained by 7.05% at last close whereas the WATT stock price plunged by 7.82% in the after-hours trading session....

AMAZON Inc. (AMZN) stock fell during after-market. Here’s the update

Amazon Inc. (NASDAQ: AMZN) stock plunged by 0.84% at last close however moving ahead the AMZAN share price also declines by 7.44% in the...

Cocrystal Pharma Inc. (COCP) stock soars during current market. Here’s what you should know

Cocrystal Pharma Inc. (NASDAQ: COCP) stock gains by 17.44% in the current market trading session. Cocrystal Pharma, Inc. is a clinical-stage biotechnology firm focused...

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

ImmunoPrecise Inc. (IPA) stock fell during pre-market. What’s the update?

ImmunoPrecise Inc. (NASDAQ: IPA) stock declined by 8.39% at last close while the IPA stock-price plunge by 4.87% in pre-market as well. ImmunoPrecise is...

ECMOHO Ltd. (MOHO) stock plunged during pre-market. Let’s see what’s happening?

ECMOHO Ltd. (NASDAQ: MOHO) stock gained by 7.05% at last close, while during pre-market MOHO stock has been seen declining by 7.75%. In China's...

Synthetic Biologics Inc. (SYN) stock plunged during pre-market. Here’s what you should know?

Synthetic Biologics Inc. (NASDAQ: SYN) stock gained by 8.09% at last close whereas the SYN stock price declines by 0.54% in the pre-market trading....

Related News

Here is why OPKO Health Inc. (OPK) stock plunged on Thursday?

OPKO Health Inc. (OPK) shares lost 7.24% in after-hours on Thursday, July 29, 2021, and closed the daily trading at $3.46 per share. in...

Why Electrameccanica Vehicles Corp. (SOLO) stock performed well on Wednesday?

Electrameccanica Vehicles Corp. (SOLO) shares gained 5.71% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $3.70 per share. in...

Encore Wire Corporation Inc. (WIRE) stock surges during current market. Here’s to know why?

Encore Wire Corporation Inc. (NASDAQ: WIRE) stock gained by 11.10% in the current market trading session. Encore Wire Corporation is a prominent manufacturer of...

Why Futu Holdings Limited (FUTU) stock is surging in pre-market on Wednesday?

Futu Holdings Limited (FUTU) shares surged 7.56% in pre-market on Wednesday, July 28, 2021, as of this writing. Yesterday in the after-hours session, FUTU's...

Mattel Inc. (MAT) stock surged during pre-market trading, post financial results announcement

Mattel Inc. (NASDAQ: MAT) stock declined by 1.2% at the last close whereas the MAT stock price rises by 5.26% in the pre-market trading...


Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free



Download Free eBook For


100% free. stop anytime no spam